The activity of ribonuclease P on precursor tRNA substrates from Escherichia coli can be abolished by pretreatment of this enzyme with micrococcal nuclease or pancreatic ribonuclease A, as well as by proteases and by thermal denaturation. Highly purified RNase P exhibits one prominent RNA and one prominent polypeptide com nent when examined in polyacrylamide gels containing sodum dodecyl sulfate. The buoyant density in CsCl of RNase P, 1.71 g/ml, is characteristic of a protein-RNA complex. The activity of RNase P is inhibited by various RNA molecules. The presence of a discrete RNA component in RNase P appears to be essential for enzymatic function. A model is described for enzyme-substrate recognition in which this RNA component plays an important role.
Ribonuclease P (1-3) is necessary for the biosynthesis of the 5' termini of tRNA molecules in Escherichia coli. This enzyme recognizes some aspect of the structural conformation rather than nucleotide sequence at is cleavage sites in tRNA precursor molecules (4) (5) (6) . Exactly how this recognition occurs is a matter for speculation (7) . In this report we show that treatment of highly purified RNase P with either micrococcal nuclease (MN) or pancreatic ribonuclease A abolishes RNase P activity. Our most highly purified RNase P preparations contain one discrete RNA species and one discrete protein species, and several kinds of RNA can inhibit the enzymatic activity. We conclude that the interaction of RNase P with its substrates depends on the presence of RNA in the enzyme complex. METHODS Preparation of RNase P. What follows is an abbreviated description of RNase P purification schemes. Complete details will be published elsewhere. Crude extracts (S30) of E. coil MRE 600 were prepared by grinding of frozen cells with alumina as described (2) . Two purification schemes were used, starting with S30. cessive washes. The final wash was with buffer A containing 0.5 M NH4Cl (now called buffer B) and the activity was eluted after about 1 liter of the last wash buffer had flowed through the column. The pooled active fractions wer-precipitated with 0.6 g of (NH4)2SO4 per ml; the precipitate was resuspended and dialyzed against buffer B to give a final volume of about 15 ml. This material was applied to a Sepharose 4B column (2.5 X 90 cm) equilibrated with buffer B and eluted with 300 ml of the same buffer. The RNase P eluted after the rRNA peak and before the 4S RNA peak. The active fractions were pooled and concentrated as described above and then applied to a Sephadex The active RNase P in the salt wash was loaded onto a DEAESephadex column and purified as described (2) . RNase P (1.8 mg), purified through the DEAE-Sephadex step, was concentrated by precipitation with (NH4)2SO4, resuspended in 0.5 ml of buffer G [20 mM Tris-HCl, pH 7.6/0.50 M NH4CI/15 mM Mg(OAc)2/6 mM 2-mercaptoethanol/5% sucrose], dialyzed against this buffer, and applied to a column of Sephadex G-200 (0.9 X 55 cm) equilibrated with buffer G. RNase P activity was eluted from this column with buffer G. One-third of the peak fractions (0.4 mg of protein in 4 ml) was pooled and concentrated by dialysis against buffer G containing 15% polyethylene glycol until the final volume was 0.3 ml. This sample was loaded in aliquots onto four 7% polyacrylamide gel columns (6 X 90 mm). The running buffer was 25 mM Tris-HCl/25 mM glycine at pH 9; the gel buffer was the same but at pH 7. The gels were run at 4 mA per column for 80 min at 40, at which time the bromphenol blue marker had run about 70 mm. Ten slices, spaced equidistant apart, were made from the top of the gel to the dye front and eluted, after mincing, with buffer G at 00. Fractions were assayed for activity as described (2, 5) . The final NH4Cl concentration in the reaction mixtures was 10 mM.
Assay of RNase P Activity. Radioactive substrates for RNase P were prepared from E. coli A49 (RNase P ts) as described (2, 5) . These were used in assay mixtures under standard conditions (2, 5) unless otherwise noted. The extent of RNase P reaction was quantitated by cutting appropriate slices out of polyacrylamide gels and assaying the amount of RNA in the slices by monitoring Cerenkov radiation.
Abbreviations: NaDodSO4, sodium dodecyl sulfate; MN Ribonuclease Inactivation of RNase P. One hundred microliters of RNase P (11 tig of protein purified through the DEAE-Sephadex step of scheme II was used in the experiments shown in Fig. 2A ; 4 ug of protein purified through the nondenaturing gel step of scheme II was used in the experiments shown in Fig. 2B ) in buffer G was mixed with 50 Ml of 10 mM CaCl2 and 6 ,ul of MN (1 mg/ml) in 1 mM NaCi. (MN from Sigma Biochemicals, Worthington Biochemicals, Schwarz/ Mann, and an authentic sample received as a kind gift from M. Laskowski, Sr., were all equally effective. Whether or not the stock solutions were made up with bovine serum albumin had no effect on the reaction.) The mixture was incubated for 30 min at 370 and then dialyzed extensively against buffer G at 40 to remove Ca2 . The RNase P was then assayed for activity using the precursor to E. coil tRNATYr as substrate. The final volume (100,Ml) contained 30 mM Tris-HCI (pH 8), 5 mM MgCI2, 0.1 mM EDTA, 0.1 mM 2-mercaptoethanol, and about 104 cpm of substrate with appropriate amounts of treated enzyme. The final concentration of NH4Cl in the assay mixtures was about 50 mM. Incubation was for 10 min at 370; the mixtures were then analyzed in acrylamide gels as described (2, 5).
Polyacrylamide-bound pancreatic RNase A (Sigma Biochemical Corp.) was prepared for use by swelling in water for 2 hr at room temperature with occasional shaking. The swollen beads were washed twice with buffer G and then resuspended in buffer G to give a final concentration of 10 mg of polyacrylamide plus enzyme per ml. RNase P was digested as follows: 50 ,l of polyacrylamide-bound pancreatic RNase A suspension was added to 50 ,l of an RNase P sample in buffer G; this gave about 0.02 Kunitz unit of pancreatic RNase A per Mg of RNA in the RNase P sample. Phenylmethylsulfonylfluoride was added to a final concentration of 10MuM in all reaction mixtures. The sample was incubated with shaking at 370 for 20 min; 150 Ml of buffer G was then added and the sample was filtered through a Swinnex filter apparatus fitted with a Millipore GAWP 01300 filter (0.45 Mum pore size) to remove the polyacrylamide beads and the pancreatic RNase A. This prevented interference of the pancreatic RNase A in subsequent assays of the RNase P sample. Control reaction mixtures contained 50
MAl of buffer G instead of the pancreatic RNase A suspension; they were incubated and filtered in parallel with the actual reaction mixtures in all experiments. RESULTS Structure of Highly Purified RNase P. RNase P. purified by either scheme I or scheme II, exhibited a simple pattern when analyzed in sodium dodecyl sulfate (NaDodSO4)/polyacrylamide gels (Fig. 1) . Scheme I enzyme, purified from a crude extract of E. coli, showed one prominent band staining with Coomassie brilliant blue (C5) and one staining with methylene blue (M2), protein and nucleic acid stains, respectively (Fig. 1A) . Estimates of the purification factor (at least 500-fold) of this enzyme were complicated by losses of activity during the steps of scheme I. Scheme II enzyme was somewhat less pure but shows the same protein band predominating and two prominent nucleic acid bands labeled Ml and M2 ( Fig. 1  B and C) . In separate experiments performed with E. coil labeled with 32P043, we have shown that Ml and M2 isolated from purified RNase P are RNA species with identical RNase Ti fingerprints, indicating that they differ in conformation only. The common RNase TI fingerprint is characteristic of a single RNA species of about 350 nucleotides and is similar to E. coil band IX RNA described by Ikemura and Dahlberg (10).
As RNase P was purified through either scheme I or II, the preparation was enriched for band Ml or M2. In addition to the NaDodSO4polyacrylamide gel analysis of purified RNase P. (A) RNase P purified through scheme I was analyzed in a NaDodS0dpolyacrylamide gel as described (8) . The gel was stained with Coomassie brillant blue and then overstained with methylene blue (9) . (Lanes 1-4) Samples from the n-octyl-Sepharose column (each containing at least 10 ,g of protein) which were dialyzed against distilled water and lyophilized before analysis. RNase P activity eluted from the column in the order of fractions 4, 3, 2, with the peak in 3. (Lane l) Sample with little RNase P activity eluting later than the peak of activity. (Lane 5) Aliquot of the sample loaded on the column. (Lane 6) Standards: Cat, catalase (Mr 58,000); LDH, lactate dehydrogenase (Mr 36,000); Hb, hemoglobin (Mr 16,000). M2, methylene blue-staining material; and C5, Coomassie blue-staining material (see B and C) in lanes 2-4. The high background in lanes 2-4 is due to some breakdown of material staining with methylene blue. (B) RNase P purified through scheme II was analyzed as described in the legend of A, except that individual cylindrical gels were used for each sample. Samples from various stages of purification and those eluted from the final nondenaturing gel step (peak of RNase P activity in fraction 5 with some activity also in fraction 4) were used. (C) Same NaDodSO4 gel analysis of the purified RNase P showing the presence of an RNA species, results from CsCl buoyant density determinations confirmed that RNA is an integral part of the enzyme.
Enzyme purified through scheme I had a buoyant density of 1.71 g/ml in CsCl. Fig. 2 illustrates the buoyant density determination of enzyme purified through the n-octyl-Sepharose step and its separation from a Drosophila virdis DNA standard sample. The RNase P buoyant density corresponds to a species of about 20% protein and 80% RNA (predominantly singlestranded) by mass, as expected from the NaDodSO4/polyac- Inactivation of RNase P by RNases. RNase P purified by either scheme I or II and pretreated with either micrococcal nuclease (MN) or pancreatic RNase A lost the ability to cleave the precursor to E. colh tRNATYr. Experiments with MN are illustrated in Fig. 3 A and B. Control pretreatments were performed in the absence of MN (Fig. 3A) and in the absence of CaCl2 (a necessary cofactor for MN activity) (Fig. 3B) . Similar 25 ,ug of RNase P (enzyme prepared through various stages of purification of scheme II gave the same result with tRNA; tRNA inhibition was measured with enzyme purified through the DEAE-Sephadex step) was used in the reaction mixtures. Purified E. coli bulk tRNA and 5S rRNA were gifts of B. Clark and R. Garber, respectively. A mixture of 16S and 23S rRNA was prepared by phenol extraction of E. coli MRE 600 ribosomes followed by chromatography of the RNA on Sephadex G-200 to remove low molecular weight species. The extent of RNase P reaction was calculated by comparing the radioactivity in undigested precursor substrate with that found in the bands corresponding to the cleavage products. The molarities of the three inhibitors were calculated from the following figures: one A2so unit equals 40 sg of RNA; average Mr of bulk tRNA is 2.5 X 104, of 5S rRNA is 4 X 104, of the 16S and 23S rRNA mixture is 8.3 X 105. Inhibition by tRNA (@); by 5S rRNA (0); by 16S and 23S rRNA mixture (0). Protein concentrations in all our experiments were determined by the method of Bradford (29 (12) we have also shown that bands stained by methylene blue in NaDodSO4 gel analyses of RNase P treated with MN were either lost entirely or significantly shifted in mobility when compared with untreated enzyme.
We have also used pancreatic RNase A immobilized on polyacrylamide beads to treat RNase P. The beads were removed by filtration from the pretreatment mixture prior to the RNase P assay and no residual RNase A activity was apparent (Fig. 3C) . Again, pretreated RNase P became inactive.
Pretreatment experiments with RNase A were carried out in the presence and absence of 10 ,M phenylmethylsulfonylfluoride, a serine protease inhibitor (14) that does not affect RNase P activity, with identical results to those shown.
Purified E. colt RNase III (15, 16 ) (a gift of J. J. Dunn) has no effect on RNase P, so the reaction with MN and RNase A may be specific for single-stranded regions in the RNA associated with RNase P.
RNase P is resistant to inactivation by several proteases (proteinase K, subtilisin BPN', subtilisin Carlsberg, and subtilopeptidase) at concentrations of 2 mg/ml in buffer G. However, RNase-free pronase (0.2 mg/ml) will inactivate 60% of RNase P activity in buffer G and 100% in the same buffer with only 20 mM NH4C1. RNase P is also more sensitive to thermal denaturation in solutions containing 10 mM NH4Cl rather than in those with 0.19 M NH4Cl. These data, and those from the buoyant density determination, indicate that RNase P is a very compact ribonucleoprotein complex in solutions of high ionic strength but is more accessible to other components in solution when in solutions of relatively low ionic strength.
Inhibition of RNase P Activity by RNA Molecules. RNase P activity can be inhibited by tRNA, 5S RNA, or by a mixture of 16S and 23S rRNA (Fig. 4) . The degree of inhibition by these molecules, when plotted as a function of the number of moles of RNA molecules used, is the same for each kind of RNA. This result suggests that the number of ends of RNA molecules encountered may play a role in the inhibitory process. tRNA can inhibit RNase P cleavage of both tRNA precursor molecules and bacteriophage 480-encoded M3 RNA (12, 17 (20, 21) . This interaction fixes the position of the enzyme in space and positions the nucleolytic subunit so that it is always at precisely the right position to cleave at the beginning of the 5' terminus of the mature tRNA sequences (7) . Studies of mutants of E. coli tRNATYr su3+ and of certain T4 suppressor tRNAs (6) show that any base change that alters the secondary and/or tertiary structure of a tRNA molecule is likely to reduce the rate of RNase P cleavage of the corresponding precursor tRNA (3) (4) (5) . Mutations or chemical alterations of the C-C-A terminus also affect RNase P cleavage (5, 22) , probably by altering enzyme binding near the nucleolytic site. Mutations in the anticodon loop, which do not affect secondary and/or tertiary structure, do not alter RNase P recognition or cleavage of its substrates; thus, this region is left uncovered by the enzyme in our scheme. This scheme is hypothetical: we have no direct evidence that the critical positioning of RNase P on precursor tRNA substrates is determined by RNA-RNA rather than by protein-RNA interactions.
In addition to the cleavage of precursor tRNAs, RNase P cleaves other substrates (7, 12, 17, 23) . The proposed secondary structures of these other substrates are similar, but differ from the proposed structure of precursor tRNA molecules. The rate of cleavage of these substrates, the precursor to E. coli 4.5 S RNA (23) (24) and tRNA (25) binding to ribosomes. Additionally, it appears that 5S rRNA of E. coli stimulates GTPase activity found in a complex with itself and three ribosomal proteins (26) . RNA ligase participates in the assembly of bacteriophage T4 tail fibers (27) . RNA is also thought to be essential for the structural organizing role of centrioles in eukaryotic cells (28) . Thus there is some precedent for believing in the involvement of RNA in intracellular protein complexes that engage in biochemical reactions.
